We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+6.93%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$36.3B
AUM Growth
-$345M
(-0.94%)
Cap. Flow
-$1.99B
Cap. Flow
% of AUM
-5.49%
Top 10 Holdings %
Top 10 Hldgs %
13%
Holding
771
New
91
Increased
196
Reduced
345
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CF Industries
CF
|
+$124M |
| 2 |
Merck
MRK
|
+$118M |
| 3 |
PNC Financial Services
PNC
|
+$109M |
| 4 |
STJ
St Jude Medical
STJ
|
+$108M |
| 5 |
Johnson Controls International
JCI
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$191M |
| 2 |
DD
Du Pont De Nemours E I
DD
|
+$184M |
| 3 |
American Airlines Group
AAL
|
+$181M |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
+$170M |
| 5 |
EMC
EMC CORPORATION
EMC
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.24% |
| 2 | Technology | 11.85% |
| 3 | Financials | 11.02% |
| 4 | Consumer Discretionary | 10.01% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Nabors Industries
NBR
$1.22B
| $3.77M | 0.01% |
6,200
+2,200
| +55% | +$1.08M |
|
627
Western Alliance Bancorporation
WAL
$8.87B
| $3.75M | 0.01% |
100,000
+75,000
| +300% | +$2.67M |
|
|
PE
628
DELISTED
PARSLEY ENERGY INC
PE
| $3.69M | 0.01% |
110,000
-50,000
| -31% | -$1.56M |
|
629
Freshpet
FRPT
$2.98B
| $3.63M | 0.01% |
419,244
| – | – |
|
630
Capital One
COF
$129B
| $3.59M | 0.01% |
+50,000
| New | +$3.43M |
|
|
SNR
631
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $3.46M | 0.01% |
300,000
| – | – |
|
|
NVET
632
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
| $3.3M | 0.01% |
795,000
-80,000
| -9% | -$379K |
|
|
SNV
633
DELISTED
Synovus
SNV
| $3.25M | 0.01% |
100,000
| – | – |
|
|
ELGX
634
DELISTED
Endologix Inc
ELGX
| $3.2M | 0.01% |
25,000
+10,000
| +67% | +$1.28M |
|
|
COL
635
DELISTED
Rockwell Collins
COL
| $3.14M | 0.01% |
+37,209
| New | +$3.14M |
|
|
WBT
636
DELISTED
Welbilt, Inc.
WBT
| $3.09M | 0.01% |
+190,425
| New | +$3.25M |
|
637
Jacobs Solutions
J
$15.7B
| $2.93M | 0.01% |
+68,434
| New | +$2.97M |
|
|
AUY
638
DELISTED
Yamana Gold, Inc.
AUY
| $2.68M | 0.01% |
621,565
-4,750,000
| -88% | -$24.5M |
|
639
Lumen
LUMN
$6.76B
| $2.67M | 0.01% |
97,222
-724,000
| -88% | -$21.1M |
|
640
Regenxbio
RGNX
$648M
| $2.45M | 0.01% |
175,000
+125,000
| +250% | +$1.38M |
|
641
Voyager Therapeutics
VYGR
$189M
| $2.4M | 0.01% |
200,000
+100,000
| +100% | +$1.35M |
|
642
DaVita
DVA
$15.3B
| $2.37M | 0.01% |
35,850
-94,900
| -73% | -$6.68M |
|
643
Rogers Corp
ROG
$2.18B
| $2.27M | 0.01% |
+37,136
| New | +$2.25M |
|
|
CRC
644
DELISTED
California Resources Corporation
CRC
| $2.24M | 0.01% |
178,894
-204,975
| -53% | -$2.34M |
|
645
News Corp Class B
NWS
$17.2B
| $2.2M | 0.01% |
154,869
-5,702
| -4% | -$77.6K |
|
|
TFCFA
646
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $2.14M | 0.01% |
88,194
-80,400
| -48% | -$2.06M |
|
647
Bausch Health
BHC
$2.25B
| $1.84M | 0.01% |
+75,000
| New | +$1.94M |
|
|
FMSA
648
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
| $1.8M | 0.01% |
+212,703
| New | +$1.58M |
|
649
Omnicom Group
OMC
$21.8B
| $1.72M | ﹤0.01% |
+20,273
| New | +$1.7M |
|
650
AC Immune
ACIU
$241M
| $1.65M | ﹤0.01% |
+100,000
| New | +$1.73M |
|
Similar funds
Adage Capital Partners's Q3 2016 Portfolio in Review
As of Q3 2016, Adage Capital Partners held 771 positions worth $36.3B, down 0.94% from $36.7B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Adage Capital Partners withdrew a net $1.99B in Q3 2016, closing 92 positions and reducing 345 holdings. Its most notable exit was MEDIVATION, INC., an estimated $170M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, Adage Capital Partners opened a new position in Kinder Morgan worth $64.8M.
- Adage Capital Partners's largest Q3 2016 buy was Kinder Morgan: 2,802,197 shares worth $64.8M.
- Adage Capital Partners added most to CF Industries in Q3 2016, an estimated $124M increase.
- Adage Capital Partners's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $191M.
- Adage Capital Partners fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $170M.
- Adage Capital Partners's ten largest holdings make up 13% of its $36.3B portfolio in Q3 2016.
- Adage Capital Partners opened 91 new positions and closed 92 in Q3 2016.
- Adage Capital Partners's portfolio value fell 0.94% quarter-over-quarter to $36.3B.
Based on Adage Capital Partners's 13F filing for Q3 2016, filed 14 Nov 2016.